Dingell Questions Ingredient Testing Exemption Rule, Cites Supply Climate
House Energy and Commerce Committee Chairman John Dingell is questioning allowing exemptions from 100 percent identity testing requirements for dietary supplement ingredients in light of mounting food safety issues
More from Archive
More from Pink Sheet
Pharmaceutical industry organizations offered alternatives to tariffs that could maintain a secure domestic supply chain in public comments filed in response to a federal 232 investigation.
Cuts to the FDA’s policy and legal personnel have prevented dozens of product-specific guidances for generic drug development from being published.
The Oncologic Drugs Advisory Committee will meet for two days in mid-May, followed by a Vaccines and Related Biological Products Advisory Committee’s review of the 2025-2026 COVID-19 vaccine formulation.